Filing Details
- Accession Number:
- 0001179110-10-007960
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-05 13:00:00
- Reporting Period:
- 2010-05-04
- Filing Date:
- 2010-05-05
- Accepted Time:
- 2010-05-05 17:19:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158223 | Affymax Inc | AFFY | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1419579 | Anne-Marie Duliege | C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-04 | 2,500 | $4.36 | 4,197 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-04 | 4,197 | $24.07 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-05-04 | 2,500 | $0.00 | 2,500 | $4.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,500 | 2016-02-09 | No | 4 | M | Direct |
Footnotes
- Includes shares aquired pursuant to the issuer's employee stock purchase plan.
- Shares were sold pursuant to a 10b5-1 Plan.
- The option is immediately exercisable but subject to the following vesting schedule: The shares vest in a series of forty-eight (48) successive equal monthly installments over a four year period measured from the vesting commencement date.